Drug discovery and development is a crucial and complex process in the pharmaceutical industry. Its goal is to get new drugs to market as quickly and efficiently as possible. However, this process involves many steps and can be time-consuming, especially in the preclinical study stage. Xybion’s Pristima XD is a preclinical laboratory solution that can help accelerate the drug discovery and development process.
This unified solution makes core business data transparent, enabling team members to make clear and informed decisions. This article highlights the critical ways in which Pristima XD can help accelerate the drug discovery and development process and help bring new drugs to market faster.
This solution’s integrated data management capabilities streamline the drug discovery and development process by providing real-time access to data, automating data entry, and enabling data sharing across teams.
As a result, Pristima XD improves collaboration and decision-making. It can also integrate with other systems, such as ELNs and LIMS, to further enhance data management, facilitate data centrality, and reduce the risk of data loss or errors.
Pristima XD’s advanced analytics capabilities, such as machine learning and AI, help speed up drug discovery by identifying new drug candidates and predicting efficacy quickly. These tools can identify new drug targets, predict drug toxicity, and optimize drug development for better results. The solution’s advanced analytics also enable predictive modeling and simulations and help identify the potential efficacy of a drug candidate before costly and time-consuming clinical trials.
The automated workflow management features accelerate drug development by streamlining tasks, reducing errors, and increasing efficiency. These features, including real-time tracking, automated task assignments, and access to SOPs, lead to a more streamlined and efficient drug development process. As a result, automated workflow management ensures tasks are completed on time and to the correct standard, reducing errors and delays.
Pristima XD’s compliance and validation features can help ensure compliance with regulatory requirements, speeding up the approval process and reducing the risk of delays. These features include e-signature, audit trails, and electronic records that meet 21 CFR Part 11, GxP, and GLP requirements. Consequently, the solution ensures that your preclinical studies meet regulatory requirements and minimizes the risk of delays in the approval process.
Xybion offers technical support and training for Pristima XD via implementation, customization, and ongoing maintenance. This ensures the proper implementation and use of the software, which ultimately speeds up the drug discovery and development process. Pristima XD provides the support you need to implement and use the software effectively, which can help you bring new drugs to market faster.
Pristima XD from Xybion is a powerful preclinical laboratory solution that can significantly improve the drug discovery and development process. Its advanced features, such as real-time data access, automated workflows, and compliance with regulatory requirements, help to streamline the process and accelerate time to market. Furthermore, the platform’s ability to provide advanced analytics and technical support makes it an invaluable tool for researchers and organizations in the preclinical space. If you’re looking to improve your preclinical studies, book a demo today.